ArticleJournal of Cancer2025

Novel Tri-Specific Immuno-Modulatory Antibody Combined with HDACi to Potentiate T Cell Activation and Anti-Tumor Efficacy.

Yidan Gou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.